New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
07:39 EDTIPXLImpax reports Q2 adjusted EPS 60c, consensus 36c
Reports Q2 revenue $188.12M, consensus $157.75M
News For IPXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 7, 2014
08:21 EDTIPXLImpax discloses receipt of subpoena from DOJ regarding generics
Impax (IPXL) disclosed in a regulatory filing that on November 3 a sales representative of Impax Laboratories received a subpoena from the Justice Departmentís Antitrust Division requesting the production of documents to and testimony before the grand jury of the Eastern District of Pennsylvania. The request relates to any communication or correspondence with any competitor, or an employee of any competitor, in the sale of generic prescription medications, Impax said. The Fly notes Lannett (LCI) disclosed yesterday in a similar filing that on that same date its Senior Vice President of Sales and Marketing was served with a grand jury subpoena relating to a federal investigation of the generic pharmaceutical industry into possible violations of the Sherman Act.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use